pfizer inc said expects file new drug application and markets this year for sertraline treatment for depression its annual report pfizer said addition drug anti depressant action sertraline currently undergoing studies explore its ability promote weight loss company officials were not immediately available comment further eli lilly and prozac antidepressant awaiting marketing approval has promise promoting weight loss pfizer also said plans file for marketing approval for certrizine novel antihistamine for hay fever and allergic reactions 1986 pfizer earned 660 mln dlrs dlrs per share revenues billion dlrs reuter 